Search results
With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
Simply Wall St. via Yahoo Finance· 31 minutes agoPharmaceuticals Insiders Aligned With All Shareholders? It's a necessity that company leaders act in...
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 5 hours agoIn May 2024 the company launched its sixth product in the US market. The company also reported net...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 4 hours agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Motley Fool via Yahoo Finance· 2 hours agoOne stock that is your typical high-risk, high-potential-reward option is Recursion Pharmaceuticals...
Collegium Pharmaceutical stock upgraded from Hold to Buy By Investing.com
Investing.com· 3 hours agoOn Friday, Collegium Pharmaceutical Inc. (NASDAQ:COLL) received an upgrade from Jefferies from Hold...
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 day agoA Different Perspective While the broader market gained around 25% in the last year, Rigel ...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 13 hours agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5%
ETF DAILY NEWS· 13 hours agoPhio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) rose 2.5% during trading on Thursday . The company traded as high as $0.75 and last traded at $0.74. Approximately ...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 12 hours agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 8 hours agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...